Literature DB >> 32656349

Knowledge, Practices, and Attitudes of Washington State Health Care Professionals Regarding Medical Cannabis.

Louise Kaplan1, Tracy Klein1, Marian Wilson2, Janessa Graves2.   

Abstract

Introduction: Health care providers in Washington State practice in a unique environment where both medical and recreational cannabis use are legal. Five types of health care providers can authorize medical cannabis. State-certified medical cannabis consultants may advise patients in a cannabis retail store regarding use and consumption. Washington State's health care professionals' perspectives about medical cannabis can inform policy-makers nationwide who are navigating challenges posed by legalization of medical and recreational cannabis. Materials and
Methods: A cross-sectional mixed-mode survey using a 26-item questionnaire was administered to a random sample of actively licensed health care professionals legally permitted to provide medical cannabis authorizations in Washington State. We describe participant demographics and summarize responses to survey questions. We report comparisons across provider types using Fisher's exact tests with a level of significance of p<0.01.
Results: Among the 1440 health care professionals invited to participate in the study, 310 respondents met eligibility criteria (response rate 24%). Only 57 respondents (18.4%) indicated having ever issued a medical cannabis authorization. Among them, 6, all naturopaths, had provided more than 500. Over half (58%) reported that they did not feel they had the knowledge and skills necessary to provide authorizations. Depending on the condition, 29-93% of respondents correctly identified conditions that qualified a patient to receive a medical cannabis authorization. Very few knew that employers are not required to provide accommodations for medical cannabis. Health care professionals (64.8%) served as the most frequent source of information regarding cannabis risks and benefits. Over half (62%) strongly or somewhat agreed that the Drug Enforcement Agency should reschedule cannabis to make it legal at the federal level.
Conclusion: A wide range of knowledge was exhibited within our sample of health care professionals regarding qualifying conditions for medical cannabis. As more states adopt comprehensive medical cannabis laws, health care professionals must be prepared to provide information to patients regarding the effects, risks, and benefits of cannabis. Standardized education could ensure that health care professionals are prepared to responsibly promote the use of cannabis when indicated for medically appropriate symptoms and conditions. A rational approach to medical cannabis is needed to assure that unforeseen consequences are mitigated. Copyright 2020, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  attitudes and practices; health care professionals; knowledge; medical cannabis; public policy; regulation

Year:  2020        PMID: 32656349      PMCID: PMC7347070          DOI: 10.1089/can.2019.0051

Source DB:  PubMed          Journal:  Cannabis Cannabinoid Res        ISSN: 2378-8763


  23 in total

1.  The clinical implications of legalizing marijuana: Are physician and non-physician providers prepared?

Authors:  Elizabeth Brooks; Doris C Gundersen; Erin Flynn; Ashley Brooks-Russell; Sheana Bull
Journal:  Addict Behav       Date:  2017-03-10       Impact factor: 3.913

2.  Colorado family physicians' attitudes toward medical marijuana.

Authors:  Elin Kondrad; Alfred Reid
Journal:  J Am Board Fam Med       Date:  2013 Jan-Feb       Impact factor: 2.657

3.  Colorado Medical Students' Attitudes and Beliefs About Marijuana.

Authors:  Michael H Chan; Christopher E Knoepke; Madeline L Cole; James McKinnon; Daniel D Matlock
Journal:  J Gen Intern Med       Date:  2017-01-17       Impact factor: 5.128

Review 4.  Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis.

Authors:  Jesse D Kosiba; Stephen A Maisto; Joseph W Ditre
Journal:  Soc Sci Med       Date:  2019-06-08       Impact factor: 4.634

5.  Pharmacy Students' Knowledge and Attitudes Regarding Medical Marijuana.

Authors:  Karen E Moeller; Barbara Woods
Journal:  Am J Pharm Educ       Date:  2015-08-25       Impact factor: 2.047

6.  Cannabis in End-of-Life Care: Examining Attitudes and Practices of Palliative Care Providers.

Authors:  Rachel Luba; Mitch Earleywine; Stacey Farmer; Melissa Slavin
Journal:  J Psychoactive Drugs       Date:  2018-05-01

7.  Medicinal Cannabis: A Survey Among Health Care Providers in Washington State

Authors:  Beatriz H Carlini; Sharon B Garrett; Gregory T Carter
Journal:  Am J Hosp Palliat Care       Date:  2016-07-11       Impact factor: 2.500

8.  Benefits and adverse effects of cannabis use among adults with persistent pain.

Authors:  Teresa Bigand; Cristina Lee Anderson; Mary Lee Roberts; Michele Rose Shaw; Marian Wilson
Journal:  Nurs Outlook       Date:  2018-12-13       Impact factor: 3.250

9.  Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study.

Authors:  Andrew A Monte; Shelby K Shelton; Eleanor Mills; Jessica Saben; Andrew Hopkinson; Brandon Sonn; Michael Devivo; Tae Chang; Jacob Fox; Cody Brevik; Kayla Williamson; Diana Abbott
Journal:  Ann Intern Med       Date:  2019-03-26       Impact factor: 25.391

10.  New York Physicians' Perspectives and Knowledge of the State Medical Marijuana Program.

Authors:  Alexandra Sideris; Fahad Khan; Alina Boltunova; Germaine Cuff; Christopher Gharibo; Lisa V Doan
Journal:  Cannabis Cannabinoid Res       Date:  2018-03-01
View more
  2 in total

1.  Therapeutic Cannabis Use in Kidney Disease: A Survey of Canadian Nephrologists.

Authors:  Kevin Gitau; Holly S Howe; Lydia Ginsberg; Jeffrey Perl; Jonathan Ailon
Journal:  Kidney Med       Date:  2022-03-18

Review 2.  Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review.

Authors:  Billy Vinette; José Côté; Ali El-Akhras; Hazar Mrad; Gabrielle Chicoine; Karine Bilodeau
Journal:  BMC Cancer       Date:  2022-03-24       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.